论文部分内容阅读
目的 探讨经导管动脉栓塞术 (TAE)治疗子宫腺肌病的临床疗效及副反应。方法 选择 14例子宫腺肌病患者 ,以Seldinger’s技术完成双子宫动脉或双髂内动脉前干超选择插管 ,造影证实后 ,用携带有抗生素的新鲜明胶海绵颗粒进行栓塞。术后 1、3、6、12个月观察其疗效。结果 TAE治疗后全部病例临床症状缓解率达 10 0 %。月经量减少 33 3% 70 0 % ,平均减少 (5 2 6± 2 0 1) % (P <0 0 1) ;13例患者在术后 2个月内痛经完全消失 ,1例治疗后明显缓解 ,至术后第 11个月痛经消失 ,术后疼痛评分及评级比术前明显降低 (P <0 0 1) ;子宫、病灶体积缩小显著 ;彩色超声显示子宫肌层及病灶内血流信号明显减少。结论 TAE治疗子宫腺肌病的近期疗效显著
Objective To investigate the clinical efficacy and side effects of transcatheter arterial chemoembolization (TAE) in the treatment of adenomyosis. Methods Fourteen patients with adenomyosis were enrolled. Seldinger ’s technique was used to perform double superselective cannulation of the uterine artery or double internal iliac arteries. After the contrast was confirmed, they were embolized with fresh gelatin sponge particles carrying antibiotics. After 1, 3, 6, 12 months to observe the effect. Results The response rate of clinical symptoms in all cases after TAE was 100%. Menstrual volume decreased 33.3% 70.0%, with an average reduction of 52.6 ± 2.01% (P <0.01). Thirteen patients completely disappeared within 2 months after operation, and one patient was relieved after treatment , The dysmenorrhoea disappeared in the 11th month after operation, the postoperative pain score and rating were significantly lower than those before operation (P <0.01); the size of the uterus and lesion was significantly reduced; color ultrasound showed obvious signal of blood flow in the myometrium and lesion cut back. Conclusion TAE treatment of adenomyosis significant effect in the near future